R&D News | pharmaphorum

News

BMS adds to IBD pipeline with $1.9bn GentiBio deal

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD).

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

AZ and Daiichi's TROP2 ADC shows promise in first-line lung ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanc

News

Closeup of X-ray photography of human brain

Merck swings back into Alzheimer's with $1.1bn Cerevance all...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevan

News

Verona cues up filings for COPD drug after it aces phase 3 t...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next

News

Tagrisso paired with Hutchmed drug clears lung cancer test

EGFR inhibitors like AstraZeneca's Tagrisso have been hugely successful in treating EGFR-positive lung cancer, but the durability of treatment is often reduced by resistance mutations.

News

x-ray image of human head with brain and electric pulses

Sanofi pauses enrolment in ex-US tolebrutinib trials

Sanofi has paused recruitment in its international phase 3 trials of BTK inhibitor tolebrutinib for multiple sclerosis, although it says studies aimed at getting US approval are on track to

BMS adds to IBD pipeline with $1.9bn GentiBio deal

AZ and Daiichi's TROP2 ADC shows promise in first-line lung ...

Merck swings back into Alzheimer's with $1.1bn Cerevance all...

Verona cues up filings for COPD drug after it aces phase 3 t...

Tagrisso paired with Hutchmed drug clears lung cancer test

Sanofi pauses enrolment in ex-US tolebrutinib trials

Moderna's Q1 revenues rocket, thanks to ex-US sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks